Clinical trials: Attention Deficit Disorders With Hyperactivity
Attention Deficit Hyperactivity Disorder
A Randomized Controlled Study of Medical-education-community Collaborated Intervention in Children With ADHD
This study is designed to test if the medical-education-community collaborated intervention can reduce the symptoms of children with Attention deficit hyperactivity disorder (ADHD) compared to routine clinical care.
- Trial name
- NCT04528433
- Testing
- Medical-education-community Collaborated Intervention, routine clinical care
- Sponsor
- Children's Hospital of Fudan University
ADHD
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
This will be a 6-week, unblinded study using the medication Strattera for children and adolescents with attention deficit hyperactivity disorder (ADHD) who failed to respond to an adequate trial of stimulant treatment.
- Trial name
- NCT00181948
- Testing
- atomoxetine (Strattera)
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Massachusetts General Hospital
Attention Deficit Disorder With Hyperactivity
Long-Duration Stimulant Treatment Study of ADHD in Young Children
This study will evaluate if Ritalin LA™ is safe and effective for ADHD treatment in 4-to-5-year olds.
- Trial name
- B-MPH (NCT00257725)
- Testing
- B-MPH
- Where
- United States
- Volunteers
- 11 people, healthy volunteers welcome
- Sponsor
- New York State Psychiatric Institute
Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose…
- Conditions
- Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children, Hypertension
- Trial name
- POPS or POP02 (NCT04278404)
- Testing
- The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:
- Where
- 52 sites in United States, Canada
- Volunteers
- 5,000 people, healthy volunteers welcome
- Sponsor
- Duke University
Attention Deficit/Hyperactivity Disorder (ADHD)
To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions.
An open label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, single dose oral bioequivalence study in healthy adult human subjects under fasting conditions.
- Trial name
- NCT07098585
- Testing
- Lisdexamfetamine capsule, Elvanse® (Lisdexamfetamine dimesylate capsules, hard)
- Where
- India
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Humanis Saglık Anonim Sirketi
Alcoholism, Attention Deficit Disorder With Hyperactivity
ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse
Some recent studies have found that adult attention deficit - hyperactivity disorder (ADHD) was frequent among patients with alcohol-dependence.
- Trial name
- AGADIR (NCT02364817)
- Testing
- cognitive and psychiatric assessment
- Where
- 3 sites in France
- Volunteers
- 113 people
- Sponsor
- University Hospital, Lille
Attention-Deficit/Hyperactivity Disorder
Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.
The purpose of this study is to characterize the safety and tolerability of TAK-137 when administered as multiple oral doses in adults with attention-deficit/hyperactivity disorder (ADHD).
- Trial name
- NCT02163915
- Testing
- TAK-137
- Where
- United States
- Volunteers
- 47 people
- Sponsor
- Takeda
Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder
SKOLKONTAKT - Social Skills Training in a School Setting
The study investigates the behavioral effects of an adapted manual-based social skills training program (SKOLKONTAKT) for the mainstream education plan delivered by school personnel, with pupils (15-20 years) with…
- Conditions
- Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Anxiety, Depression
- Trial name
- SKOLKONTAKT (NCT04302818)
- Testing
- SKOLKONTAKT, Social activity group
- Where
- Sweden
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Karolinska Institutet
Smoking, ADHD
Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate how nicotine, withdrawal from nicotine, and methylphenidate (a drug used for the treatment of ADHD) affect the brain of smokers with and without ADHD while doing tasks in an functional…
- Trial name
- NCT01123668
- Where
- United States
- Volunteers
- 101 people, healthy volunteers welcome
- Sponsor
- Duke University
Attention Deficit Hyperactivity Disorder
Cognitive-Behavioral Therapy for Adults With ADHD: A Qualitative Study
This is a qualitative study of participants who have taken part in a randomized controlled trial (RCT) of a new treatment protocol based on cognitive-behavioral therapy for adults with attention deficit/hyperactivity disorder…
- Trial name
- NCT05037903
- Testing
- Cognitive-behavioral therapy
- Where
- Sweden
- Volunteers
- 14 people
- Sponsor
- Karolinska Institutet
ADHD
PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children
To assess the effect of phosphatidylserine-omega-3 consumption on the immune system parameters in children suffering from attention and concentration deficits.
- Trial name
- ADHD-3 (NCT00700323)
- Testing
- PS-Omega3 conjugate supplementation
- Where
- Israel
- Volunteers
- 45 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
ADHD
Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
This study is the first to systematically evaluate the efficacy of single and combined academic accommodation, behavioral treatment, and medication treatment in a large sample of children with ADHD.
- Trial name
- NCT05469386
- Testing
- Methylphenidate Hydrochloride ER, Behavioral classroom, General Classroom
- Where
- 2 sites in United States
- Volunteers
- 288 people
- Sponsor
- Florida International University
Traumatic Brain Injury, TBI
Methylphenidate for Attention Problems After Pediatric TBI
Traumatic Brain Injury (TBI) - methylphenidate treatment
- Conditions
- Traumatic Brain Injury, TBI, ADHD
- Trial name
- NCT01933217
- Testing
- Methylphenidate
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Children's Hospital Medical Center, Cincinnati
ADHD
Refining the Shared Decision Making Process Survey in ADHD Medication Decisions
This is a retrospective observational survey study. We will survey a sample of adult parents or legal guardians who have a child who has been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) and who discussed ADHD…
- Trial name
- NCT05048186
- Testing
- Attention Deficit Hyperactivity Disorder Treatment Decision Aid
- Where
- United States
- Volunteers
- 512 people
- Sponsor
- Massachusetts General Hospital
Attention Deficit-Hyperactivity Disorder
Biomarker Research in ADHD: the Impact of Nutrition
Attention deficit hyperactivity disorder (ADHD) is the most common childhood behavioural disorder, causing significant impediment to a child's development. The exact aetiology of ADHD is still unknown.
- Trial name
- BRAIN (NCT03440346)
- Testing
- Few-foods diet
- Where
- Netherlands
- Volunteers
- 100 people
- Sponsor
- Wageningen University
ADHD, Stimulant-Induced Euphoria
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
The purpose of this study is to a) assess the efficacy of naltrexone in preventing stimulant-induced euphoria in adults with ADHD, b) assess whether naltrexone will interfere with the clinical efficacy of stimulants in treating…
- Trial name
- NCT01673594
- Testing
- SODAS MPH, Naltrexone
- Where
- United States
- Volunteers
- 37 people
- Sponsor
- Massachusetts General Hospital
Attention Deficit/Hyperactivity Disorder
Explore the Association Between the Emotion Recognition and the Attention Processing Under the Emotional Stimuli in ADHD
Lots of studies suggest that children with ADHD have deficits in facial emotion recognition, especially for the negative emotion.
- Trial name
- NCT02017483
- Where
- Taiwan
- Volunteers
- 200 people
- Sponsor
- National Taiwan University Hospital
Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders
Treatment of ADHD Using High and Low Frequency Paired Associative Deep Transcranial Magnetic Stimulation
This study investigates the effects of high and low-frequency paired associative deep transcranial magnetic stimulation (dTMS) on adults with Attention Deficit Hyperactivity Disorder (ADHD).
- Conditions
- Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders, Prefrontal Cortex Dysregulation, Cortical Arousal Imbalance
- Trial name
- NCT07105475
- Testing
- Paired Associative Transcranial Magnetic Stimulation (TMS)
- Where
- Israel
- Volunteers
- 90 people
- Sponsor
- Ben-Gurion University of the Negev
Attention Deficit-Hyperactivity Disorder
TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study
The aim of this observational cross-sectional study is to evaluate the streptococcal infection (clinical history, ASLO title and anti-DNAse title B) and autoimmunity (ABGA antibodies) in a sample of 100 adult patients diagnosed…
- Trial name
- TLR; (NCT04038073)
- Testing
- Antistreptolysin O Test, Anti-Deoxyribonuclease B, TLR, MyD88, IRAK-4 polymorphism
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University of Turin, Italy
Attention Deficit Hyperactivity Disorder (ADHD)
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of SHP465 in children aged 4 to 5 years with ADHD after multiple daily doses of 6.25 milligram (mg) SHP465
- Trial name
- NCT03327402
- Testing
- SHP465
- Where
- 8 sites in United States
- Volunteers
- 24 people
- Sponsor
- Shire